SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-023351
Filing Date
2022-02-15
Accepted
2022-02-14 19:14:02
Documents
5
Effectiveness Date
2022-02-15

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm226346d1_s8.htm S-8 43686
2 EXHIBIT 5.1 tm226346d1_ex5-1.htm EX-5.1 8445
3 EXHIBIT 23.1 tm226346d1_ex23-1.htm EX-23.1 1777
4 EX-FILING FEES tm226346d1_ex107.htm EX-FILING FEES 27954
5 GRAPHIC image_001.gif GRAPHIC 1594
  Complete submission text file 0001104659-22-023351.txt   85198
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-262731 | Film No.: 22636254
SIC: 2836 Biological Products, (No Diagnostic Substances)